The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...

Addition of the immunotherapy drug pembrolizumab to standard of care ... Duke University and Princess Margaret Cancer Centre, ...

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition ...

Researchers from the Data Science and Artificial Intelligence Institute (DATAI) at the University of Navarra have developed ...

Researchers think they’ve figured out why cancer treatments that harness a person’s immune system to fight a tumor can ...